Dental Care Clinics in Putnam Valley, NY Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Comprehensive Dental Care Of Westchester And Putnam Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 17 Oscawana Lake Rd, Putnam Valley, NY 10579 Phone: 845-528-2500 Fax: 845-528-2502 |
Envision Dental Care Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 17 Oscawana Lake Rd, 1st Floor, Putnam Valley, NY 10579 Phone: 845-528-2500 Fax: 845-528-2502 |
News Archive
New study in fruit flies offers clues to delay human aging
One of the few reliable ways to extend an organism's lifespan, be it a fruit fly or a mouse, is to restrict calorie intake. Now, a new study in fruit flies is helping to explain why such minimal diets are linked to longevity and offering clues to the effects of aging on stem cell behavior.
Chronic kidney disease and women's sexuality and gynecologic health
Chronic kidney disease (CKD) exacts a significant toll on a woman's sexuality and gynecologic health. The various effects of kidney failure and its treatments on women's sexual health from adolescence through menopause will be the topic of an in-depth series of presentations at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
SponsorFit launches initiative to provide free exercise programs to educators
SponsorFit LLC, a privately held, hybrid company consisting of fitness, advertising, and marketing, today announced the launch of their initiative to provide free exercise programs to educators in the Washington, D.C. metro area through corporate sponsorships, whereby sponsors will receive numerous advertising impressions in a variety of benefits.
Low potassium levels linked to increased mortality in heart failure patients
New research from University of Alabama at Birmingham indicates that patients with heart failure who have low to low-normal serum potassium levels are at increased risk of death.
Array BioPharma signs agreement with Novartis for worldwide development of ARRY-162
Array BioPharma Inc. today announced that it has entered into an agreement with Novartis for the worldwide development of the small-molecule MEK inhibitors ARRY-162, currently in a Phase 1 cancer trial, its back-up, ARRY-300, and other MEK inhibitors.
› Verified 9 days ago